Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women

Exclusion Criteria

• •Subjects must not
• •require treatment with anti-androgens, high-dose oral or injectable corticosteroids, tamoxifen or other selective estrogen receptor modulators,
• •have used androgen therapy within 2 months of randomization,
• •have a history of estrogen-dependent neoplasia or any gynecologic cancer,
• •have a history of cancer of any kind in the past 10 years prior to randomization,
• •have a history of malignant melanoma or a history of invasive cancer at any time,
• •have a screening mammogram with any finding that requires follow up within 6 months of randomization,
• •have a history of myocardial infarction, coronary revascularization or stroke within 12 months of randomization,
• •have any medical condition associated with predicted survival of less than 3 years in the judgment of the Investigator.